Connect with us

MARKETS

Is Supreme Cannabis Company Inc (OTCMKTS:SPRWF) Heading for Bigger Things?

Published

on

Supreme Cannabis Company Inc (OTCMKTS:SPRWF) should be on the radar as a potential breakout candidate if the stock is able to push above its key resistance level in the vicinity of $1.85/share. In addition, the company just announced a realignment of its senior leadership in order to further position the Company for global growth and continued operational success.

As stated in its release, “John Fowler, currently Chief Executive Officer of the Company, will assume the role of President of the Company, and Navdeep Dhaliwal, currently the President of the Company, will assume the role of Chief Executive Officer of the Company, effective at the end of the business day on September 24, 2018. Both individuals will continue to serve as members of the Company’s board of directors.”

Supreme Cannabis Company Inc (OTCMKTS:SPRWF), carrying a capital value in the market of $454.44M, is a Canadian publicly traded company committed to providing premium brands and products that proudly reflect its consumers, people, and uniquely innovative culture. The Company’s portfolio includes its wholly-owned subsidiary and flagship brand 7ACRES. 7ACRES is a federally licensed producer of medical cannabis operating inside a 342,000-square-foot facility in Kincardine, Ontario. 7ACRES is dedicated to providing consumers with a premium-quality product that recognizes its customers are informed, discerning and value a brand and culture that aligns with their principles.

7ACRES brand success has been reflected in provincial supply agreements, where 7ACRES’ product is consistently listed in the highest brand category available to recreational consumers. The Company’s growing portfolio also includes an equity investment and long-term global distribution partnership with Lesotho-based Medigrow for the exporting of medical-grade cannabis oil.

Moreover, the company focuses on the production and sale of medical marijuana in Canada. The company was formerly known as Supreme Resources Ltd. and changed its name to Supreme Pharmaceuticals Inc. in February 2014. Supreme Pharmaceuticals Inc. was incorporated in 1979 and is headquartered in Vancouver, Canada.

As they put it, “The Supreme Cannabis Company has consistently set the standard for innovation in the sector, including the design of growing facilities and development of operational excellence metrics. We are confident that together with our flagship brand, proprietary technology and products, truly unique culture, and industry-leading team, we will deliver consistent long-term value creation to our shareholders.”

 

Movin’ On Up

As discussed earlier, the company has been building out its executive team. In addition, SPRWF also just announced that the Company’s wholly-owned subsidiary, 7ACRES, has entered into a supply agreement to provide dried cannabis to Tilray Canada Ltd.

“We are excited to be entering into this agreement with Tilray, an organization – like Supreme Cannabis – that focuses on the end user and demands leading quality assurance standards,” said John Fowler, President of The Supreme Cannabis Company.

“Tilray has built an industry-leading global medical distribution platform, which has resulted in robust demand for high-quality cannabis products. We are happy to provide 7ACRES premium products alongside Tilray’s well-regarded and existing lineup to support medical patients around the world.”

Unless you have been living under a rock, anything associated with TLRY has been big news. Given the elevation in board and C-suite talent, and this new agreement, we wouldn’t be surprised to see some interesting things ahead for SPRWF.

This is an exciting story, and we look forward to a follow-up chapter as events transpire.

Business

Phoenix Life Sciences International (OTC: PLSI)

Published

on

In the healthcare sector, Phoenix Life Sciences International Limited operates as a Biotech and Pharma company. It engages in research on organically produced plants such as cannabis and manufactures and distributes adaptive healthcare solutions. Its natural healthcare solutions are targeted at a wide array of conditions including diabetes, pain, cancers, and gastrointestinal problems. For the next five years, the company aims to expand its services to at least 2.5 million patients around the world.

The shares of the company are available for trading over the counter (OTC) under the ticker symbol “PLSI.” It has its headquarters in Denver, Colorado.

Industry Overview
The healthcare sector has been traditionally stable. Companies in the biotech and pharmaceutical industry especially have experienced tremendous advances in recent years. The fast-growing cannabis industry has contributed in many ways to the growth of pharmaceutical and biotech firms. Many of them are investing millions in the medical cannabis market to develop cannabinoid products.

The prospect in the cannabis market is great and should be explored. And Phoenix Life Sciences International Limited is doing that.
P
LSI: A Successful Product of Strategic Partnerships
The most recent of Phoenix Life Sciences International Limited’s (PLSI) deals came through on June 4, 2019. The company announced it had signed an exclusive 25-year Diabetes Management Program deal with the Ministry of Health of the Republic of Vanuatu.

As part of the deal, it would also be granted a global medical cannabis export license. Vanuatu is estimated to have over 50,000 Type 2 diabetics and an expected 50,000 high-risk pre-diabetics. This deal is in furtherance of the company’s strategy of international market expansion.

Financials Indicate Long-Term Growth
For the nine months ended November 30, 2018, Phoenix Life Sciences International Limited did not report its revenues. However, it recorded a net loss of $3.3 million mainly due to an increase in operations expenses. Basic Earnings per Share (EPS) also decreased during the same period.

Following the 2018 merger and consolidation, to realise its plans to uplist to the OTCQB market, the company recently filed its 2017 and 2018 quarterly reports, and will also be subsequently making filings to stay current with its reporting requirements with the SEC. Uplisting will enable the company to access more funds for the execution of its next developmental stages.
Conclusion

The fundamentals of Phoenix Life Sciences International Limited are not presently attractive. The company is being burdened with rising operations expenses. This is expected as the company just passed through a major restructuring process and is focused on expanding to international markets.
The international expansion efforts should result in increased revenues. The uplisting would also create more access to funds. Both would contribute to long-term growth.

Moreover, at the current market price of $10.24, the company (OTC: PLSI) is trading far away from its 52-week high of $48.25, meaning a lot of upside potential. Hence, for the long-term investor, this might be a good time to buy.

Continue Reading

MARKETS

The Bounce Takes Hold in Medmen Enterprises Inc (OTCMKTS:MMNFF) on Geographic Expansion

Published

on

Medmen Enterprises Inc (OTCMKTS:MMNFF) has been one of our favorite ideas in the cannabis space in this pullback because the company’s strong geographic diversification in the US marketplace. As a case in point, the company just announced that it has signed a definitive agreement to acquire control of Kannaboost Technology Inc., giving the company a stronghold in the Arizona market.

According to the company’s most recent press release, “Level Up holds licenses for two vertically-integrated operations in Arizona, which include retail locations in Scottsdale and Tempe, as well as 25,000 square feet of cultivation and production capacity in Tempe and Phoenix. As part of the transaction, the Company will also receive a 40 percent stake in top-selling brand K.I.N.D. Concentrates (“K.I.N.D.”), which is currently distributed in over 90 percent of the dispensaries in Arizona.”

Medmen Enterprises Inc (OTCMKTS:MMNFF), together with its subsidiaries, operates in the cannabis space in the United States.

MMNFF, more broadly, is a leading cannabis company in the U.S. with assets and operations across the country. Based in Los Angeles, MedMen brings expertise and capital to the cannabis industry and is one of the nation’s largest financial supporters of progressive marijuana laws.

The company cultivates, produces, possesses, uses, and distributes/retails cannabis in the recreational and medicinal cannabis marketplace. As of June 6, 2018, it owned and operated 18 licensed cannabis facilities under the MedMen brand name in California, Nevada, and New York.

The company frames itself as “the preeminent cannabis company in the United States” with multiple assets and operations in California, Nevada, New York, and Florida. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail, and is one of the most well-recognized cannabis brands in the world today.

Headquartered in Los Angeles, MedMen employs more than 800 workers across the United States. It was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who saw not just a tremendous business opportunity in the growing legalization of marijuana, but a chance to re-define our society’s relationship with cannabis. MedMen supports sensible, clear and just drug laws.

The Company is the single largest financial supporter of progressive marijuana laws at the local, state and federal levels, giving directly to pro-legalization groups, industry organizations and political candidates.

The company is headquartered in Culver City, California. MedMen Enterprises Inc. is a subsidiary of The Medmen Of Nevada 2 Llc.

Moreover, the company operates as a cannabis company in the United States. The company cultivates, produces, possesses, uses, and distributes/retails cannabis in the recreational and medicinal cannabis marketplace. It owns and operates 19 licensed facilities in California, Florida, Nevada, and New York. The company is headquartered in Culver City, California.

 

Onward and Upward

As noted above, MMNFF just announced that it has signed a definitive agreement to acquire control of Kannaboost Technology Inc. and CSI Solutions LLC, collectively referred to as “Level Up,” in a cash and stock transaction valued at $33,000,000.

The stock is up on the news. Overall, shares of MMNFF have rallied about 20% over the past week. That sets up an interesting context for the action tomorrow. Shares of the stock have powered higher over the past month, rallying roughly 42% in that time on strong overall action.

“We have worked tremendously hard to build a company that puts the needs of patients in our local communities first,” said Michael Colburn, co-founder of Level Up. “This marks an exciting new chapter for our brands and for the medical marijuana patients who have supported us,” added Daryll DeSantis, Level Up co-founder.

Medmen Enterprises Inc (OTCMKTS:MMNFF) has about $12.2M in cash on the books against to a mountain of over $86M in total current liabilities. The company has been pulling in significant revenues, with over $7M in Q1 of this year, representing over 630% quarterly y/y growth on the top line.

Continue Reading

MARKETS

Medmen Enterprises Inc (OTCMKTS:MMNFF) Levels Up with New Acquisition

Published

on

Medmen Enterprises Inc (OTCMKTS:MMNFF) shares ripped on Thursday to break above the stock’s 50-day simple moving average. The move came apparently in response to the company’s announcement that it has signed a definitive agreement to acquire control of Kannaboost Technology Inc. and CSI Solutions LLC, collectively referred to as “Level Up,” in a cash and stock transaction valued at $33,000,000.

According to the release, “Level Up holds licenses for two vertically-integrated operations in Arizona, which include retail locations in Scottsdale and Tempe, as well as 25,000 square feet of cultivation and production capacity in Tempe and Phoenix. As part of the transaction, the Company will also receive a 40 percent stake in top-selling brand K.I.N.D. Concentrates, which is currently distributed in over 90 percent of the dispensaries in Arizona.”

Medmen Enterprises Inc (OTCMKTS:MMNFF), together with its subsidiaries, operates in the cannabis space in the United States.

MMNFF, more broadly, is a leading cannabis company in the U.S. with assets and operations across the country. Based in Los Angeles, MedMen brings expertise and capital to the cannabis industry and is one of the nation’s largest financial supporters of progressive marijuana laws.

The company cultivates, produces, possesses, uses, and distributes/retails cannabis in the recreational and medicinal cannabis marketplace. As of June 6, 2018, it owned and operated 18 licensed cannabis facilities under the MedMen brand name in California, Nevada, and New York.

The company frames itself as “the preeminent cannabis company in the United States” with multiple assets and operations in California, Nevada, New York, and Florida. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail, and is one of the most well-recognized cannabis brands in the world today.

Headquartered in Los Angeles, MedMen employs more than 800 workers across the United States. It was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who saw not just a tremendous business opportunity in the growing legalization of marijuana, but a chance to re-define our society’s relationship with cannabis. MedMen supports sensible, clear and just drug laws.

The Company is the single largest financial supporter of progressive marijuana laws at the local, state and federal levels, giving directly to pro-legalization groups, industry organizations and political candidates.

The company is headquartered in Culver City, California. MedMen Enterprises Inc. is a subsidiary of The Medmen Of Nevada 2 Llc.

Moreover, the company operates as a cannabis company in the United States. The company cultivates, produces, possesses, uses, and distributes/retails cannabis in the recreational and medicinal cannabis marketplace. It owns and operates 19 licensed facilities in California, Florida, Nevada, and New York. The company is headquartered in Culver City, California.

 

A Boost

As we discussed earlier, MMNFF just announced that it has signed a definitive agreement to acquire control of Kannaboost Technology Inc. and CSI Solutions LLC, collectively referred to as “Level Up,” in a cash and stock transaction valued at $33,000,000.

“This acquisition strengthens our presence in one of the top cannabis markets in the U.S.,” said Adam Bierman, MedMen chief executive and co-founder. “We will continue to identify highly accretive transactions in core states and remain laser-focused on executing our retail playbook.”

MMNFF has responded well, rallying about 11% over the past five days, with this news clearly driving the action. Shares of the stock have powered higher over the past month, rallying roughly 34% in that time on strong overall action.

“We have worked tremendously hard to build a company that puts the needs of patients in our local communities first,” said Michael Colburn, co-founder of Level Up. “This marks an exciting new chapter for our brands and for the medical marijuana patients who have supported us,” added Daryll DeSantis, Level Up co-founder.

Medmen Enterprises Inc (OTCMKTS:MMNFF) had no reported sales in its last quarterly financial data. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($0 against $0, respectively).

Continue Reading
Advertisement

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Trade


FEATURED STORIES

Business2 days ago

Canopy Rivers Inc. (OTCMKTS:CNPOF) Portfolio Company TerrAscend Corp (OTCMKTS:TRSSF) To Acquire State Flower Brand

Post Views: 237 Canopy Rivers Inc. (OTCMKTS: CNPOF) has announced that portfolio company TerrAscend Corp (OTCMKTS: TRSSF) has entered a...

Business2 days ago

Auxly Cannabis Group Inc. (OTCMKTS:CBWTF) Subsidiary KGK Science Receives Cannabis Research Licence

Post Views: 126 Auxly Cannabis Group Inc. (OTCMKTS:CBWTF) has announced that its wholly-owned subsidiary KGK Science Inc. has received a...

Business3 days ago

SinglePoint Inc. (OTCMKTS:SING) Subsidiary To Offer Energy Solutions To The First Ever Hemp Distribution Centre

Post Views: 235 SinglePoint Inc. (OTCMKTS:SING) has announced that its subsidiary Direct Solar of America and GSX international Group along...

Business3 days ago

Omni Health Inc. (OTCMKT:OMHE) Announce Acquisition Of Two Medical Technology Companies

Post Views: 153 Omni Health Inc. (OTCMKT:OMHE) has announced that it has completed agreements for the acquisition of 2 privately...

BENEFITS OF CBD4 days ago

How A Simple CBD Tincture with Childs Epilepsy and Seizures

Post Views: 295 With all the attention CBD has been getting in and outside mainstream media, it was only going...

Business4 days ago

LinkResPet (OTCMKTS:LRSV) and American Premium Water Corp (OTCMKTS:HIPH) Launch LYNKS CBD Pet Water

Post Views: 191 LinkResPet (OTCMKTS:LRSV) has announced that it’s American Premium Water Corp (OTCMKTS:HIPH) joint venture LYNKS CBD Pet Water...

Business4 days ago

Puration Inc. (OTCMKTS:PURA) and Kali Extracts Inc. (OTCMKTS:KALY) Products Discounted On Labour Day On USMJ Site

Post Views: 114 The partnerships between Puration Inc. (OTCMKTS:PURA) and Kali Extracts Inc. (OTCMKTS:KALY) is already offering promising returns in...

BENEFITS OF CBD5 days ago

Benefits of CBD and Endocrine Diseases

Post Views: 215 The endocrine system is a collection of glands all over the body that is responsible for the...

Business5 days ago

Tilray Inc. (NASDAQ:TLRY) Signs Definitive Agreement To Acquire FOUR20 Investments Ltd

Post Views: 135 Tilray Inc. (NASDAQ:TLRY) has announced that it has signed a definitive agreement through which it’s subsidiary High...

Business5 days ago

Golden Leaf Holdings Ltd. (OTCMKTS:GLDFF) Announces Its Q2 2019 Financial Results and Business Update

Post Views: 131 Golden Leaf Holdings Ltd. (OTCMKTS:GLDFF) has announced its Q2 2019 financial results as well as provided general...

Whats Hot

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play